Allscripts Announces Expanded Share Repurchase Program

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Allscripts Announces Expanded Share Repurchase Program

CHICAGO, Nov. 17, 2016 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions (NASDAQ: MDRX ) announced today that its Board of Directors has approved a new stock repurchase program under which Allscripts may purchase up to $200 million of its common stock through December 31, 2019.

The new stock repurchase program supersedes the previously existing stock repurchase program, which authorized Allscripts to repurchase $150 million of its common stock through December 31, 2018. Under the prior program, Allscripts repurchased 8.1 million shares or approximately $97 million of shares of common stock.

Under the new program, Allscripts could repurchase approximately 18.4 million additional shares, or approximately 10 percent of the company's outstanding shares as of October 30, 2016 based on the November 17, 2016 closing price.

"Extending and expanding Allscripts share repurchase program reflects our ongoing commitment to enhance shareholder value," said Melinda Whittington, Allscripts Chief Financial Officer. "The new program represents an attractive component of our capital deployment strategy and our continued confidence in Allscripts long-term growth prospects and free cash flow generation potential.”

Allscripts plans to repurchase shares from time to time in the open market or in privately negotiated transactions, subject to market conditions. There is no guarantee as to the exact number of shares or value that will be repurchased under the stock repurchase program, and Allscripts may discontinue purchases at any time. Whether Allscripts makes any repurchases will depend on many factors, including but not limited to its business and financial performance, the business and market conditions at the time, including the price of Allscripts shares, and other factors that management considers relevant.

About Allscripts Allscripts (NASDAQ: MDRX ) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com , Twitter , YouTube and It Takes A Community: The Allscripts Blog .

© 2016 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

For more information contact:

Investors : Seth Frank 312-506-1213 seth.frank@allscripts.com

Media : Concetta DiFranco 312-447-2466 concetta.difranco@allscripts.com

Forward-Looking Statements This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. See our Annual Report on Form 10-K for 2015 and other public filings with the   SEC   for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 1

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 34

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Dickinson Brands Celebrates Witch Hazel Legacy with Event

Updated Category News Views 0

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 1

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Angels on Call Sets Benchmark for Specialized Homecare

Updated Category News Views 2

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 41

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 1

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 0

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 2

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into FGI Industries' Upcoming Earnings Report

Updated Category News Views 143

FGI Industries Earnings Report Overview FGI Industries (NASDAQ: FGI) is preparing to reveal its quarterly earnings, creating anticipation among investors. Although the report was initially set for a future date, the expectation remains high for significant news regarding the company's performance and guidance. Expected Earnings and Analyst Insights Analysts project that...

Continue Reading
US SMEs Shift Focus Towards High-Quality and Trendy Products

Updated Category News Views 211

Changing Priorities for US SMEs in Product Sourcing Small and medium-sized enterprises (SMEs) in the United States are gearing up for significant shifts in how they source products in the coming year. A striking 44% of these businesses are on the lookout for new suppliers, prioritizing cost efficiency and product quality above all else. This transformation is highlighted...

Continue Reading
TD Bank Resolves AML Issues, Boosts Analyst Confidence

Updated Category News Views 87

TD Bank's Outlook After Resolving AML Issues Scotiabank has reaffirmed its Sector Outperform rating for Toronto-Dominion Bank (TD:CN) (NYSE: TD), setting its price target at Cdn$86.00. This positive assessment comes after the resolution of TD's anti-money laundering (AML) challenges in the United States, which had raised uncertainties following the failed acquisition of...

Continue Reading
Centene Corporation Urges Shareholders to Reject TRC Offer

Updated Category News Views 139

Centene Corporation Advises Shareholders Centene Corporation (NYSE: CNC) has recently communicated important news regarding an unsolicited offer from TRC Capital Investment Corporation. TRC has proposed a 'mini-tender' offer to purchase up to 4 million shares of Centene's common stock at a price of $24.75 per share. This offer, however, is lower than the current market...

Continue Reading
Liberty Defense's New Offering: What It Means for Investors

Updated Category News Views 289

Liberty Defense Holdings Announces an Exciting New Offering Liberty Defense Holdings Ltd. (NASDAQ: LDDFF) is making waves with its announcement regarding an overnight marketed offering of units. This offering aims to finance their innovative journey in creating AI-based detection solutions for concealed weapons and potential threats in various sectors. As a key player in...

Continue Reading